Document Detail


Endotoxin in pooled pericardial blood contributes to the systemic inflammatory response during cardiac surgery.
MedLine Citation:
PMID:  11001165     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Although endotoxin has been implicated as an important contributor to the systemic inflammatory response (SIR) during cardiopulmonary bypass (CPB), its source remains unclear. While gut translocation has traditionally been perceived as the primary source of endotoxemia, accumulation of endotoxin in pooled pericardial blood may represent an additional source of endotoxin that is continually reinfused into the CPB circuit. Eighteen patients undergoing primary coronary revascularization procedures were prospectively evaluated. Shed blood pooled in the pericardial space was returned to the CPB circuit through cardiotomy suction catheters at 45 min after placement of the aortic cross-clamp. Simultaneous samples of pooled pericardial and peripheral arterial blood were obtained and analyzed by a limulus amebocyte lysate assay for the determination of endotoxin concentration, and an enzyme-linked immunosorbent assay for tumor necrosis factor (TNF-alpha) levels. Significant elevations in endotoxin were demonstrated in pooled pericardial blood samples compared with arterial blood (3.5 +/- 0.5 vs 0.8 +/- 0.2 pg/ml; p < 0.05). TNF-alpha levels were below the limits of detection in both samples. These data implicate pooled pericardial blood as an important primary source of endotoxin that, when continually reinfused throughout CPB, may contribute to the overall SIR. Because endotoxemia has been identified as an important predictor of adverse outcomes following cardiac surgery, removal of endotoxin antigen in shed pericardial blood, prior to its reinfusion into the CPB circuit, may provide a directed means to improve perioperative outcome without compromising established blood conservation techniques.
Authors:
T Spanier; K Tector; G Schwartz; J Chen; M Oz; J Beck; L Mongero
Related Documents :
8010425 - Phenylephrine does not reduce cerebral perfusion during canine cardiopulmonary bypass.
17972455 - Preventing gaseous microemboli during blood sampling and drug administration: an in vit...
6769365 - Effect of high vs. low arterial blood oxygen content on cerebral energy metabolite leve...
20194585 - Preservation of endothelium nitric oxide release during beating heart surgery with resp...
10817945 - Hemodynamics analyses of arterial expansions with implications to thrombosis and resten...
7933445 - Accuracy of enteral pumps: in vitro performance.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Perfusion     Volume:  15     ISSN:  0267-6591     ISO Abbreviation:  Perfusion     Publication Date:  2000 Sep 
Date Detail:
Created Date:  2000-12-26     Completed Date:  2001-03-15     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8700166     Medline TA:  Perfusion     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  427-31     Citation Subset:  IM    
Affiliation:
Division of Cardiothoracic Surgery and Perfusion, Columbia University, USA. tbs8@columbia.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Cardiopulmonary Bypass / adverse effects*
Endotoxins / blood*,  pharmacology
Enzyme-Linked Immunosorbent Assay
Equipment and Supplies / microbiology
Female
Humans
Inflammation / chemically induced*,  etiology
Limulus Test
Male
Middle Aged
Myocardial Revascularization / adverse effects
Pericardium / chemistry*
Prospective Studies
Tumor Necrosis Factor-alpha / metabolism
Chemical
Reg. No./Substance:
0/Endotoxins; 0/Tumor Necrosis Factor-alpha

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Plasma endotoxin concentrations during cardiac surgery may be related to atherosclerosis.
Next Document:  Impaired carbon dioxide transport during and after cardiopulmonary bypass.